Exome Asset Management LLC Natera, Inc. Transaction History
Exome Asset Management LLC
- $112 Billion
- Q1 2025
A detailed history of Exome Asset Management LLC transactions in Natera, Inc. stock. As of the latest transaction made, Exome Asset Management LLC holds 18,650 shares of NTRA stock, worth $2.94 Million. This represents 2.34% of its overall portfolio holdings.
Number of Shares
18,650
Previous 22,450
16.93%
Holding current value
$2.94 Million
Previous $3.55 Billion
25.79%
% of portfolio
2.34%
Previous 2.67%
Shares
3 transactions
Others Institutions Holding NTRA
# of Institutions
652Shares Held
126MCall Options Held
975KPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA12.4MShares$1.95 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.5MShares$1.66 Billion0.18% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.16 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.07 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.55MShares$717 Million3.7% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $15.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...